ACR2024 - Day1a

Dive into the fascinating developments from ACR Convergence 2024! Discover the pressing need for improved monitoring in scleroderma-associated lung disease. Uncover insights into the survival rates of lung cancer patients with rheumatoid arthritis, showing no significant mortality difference. Explore the implications of tapering prednisone in granulomatosis with polyangiitis, highlighting crucial flare rate findings. Lastly, learn how ACR is evolving its educational practices through digital tools and social media, enhancing collaboration and knowledge-sharing.